Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to identify the prevalence rate and risk factors for pulmonary complications in patients with critical trauma who intubated and mechanical ventilation.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| number of participants with pulmonary atelectasis | from the date of randomization until the date of first documented of atelectasis, assessed up to 1 years |
| Measure | Description | Time Frame |
|---|---|---|
| number of participants with pneumonia | from the date of randomization until the date of first documented of pneumonia, assessed up to 1 years | |
| number of participants with pleural effusion | from the date of randomization until the date of first documented of pleural effusion, assessed up to 1 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
The critically traumatic patients who were admitted to the traumatic surgical intensive care unit at Khon Kaen Hospital (February 2016 to February 2017).
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Khon Kaen University | Khon Kaen | 40002 | Thailand |
Not provided
| ID | Term |
|---|---|
| D001261 | Pulmonary Atelectasis |
| D014947 | Wounds and Injuries |
| ID | Term |
|---|---|
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| number of participants with abnormal laboratory values | the laboratory test include arterial blood gases (ABG), Clinical chemistry test (i.e. Blood urea nitrogen, Creatinine, Sodium, Potassium, Phosphorus, Chloride, Magnesium). | from the date of randomization until the date of first documented of pleural effusion, assessed up to 1 years |
| number of participants with adverse events that are related to treatment | These data are collected from medical records (i.e. arrhythmia, hypoxia) | from the date of randomization until the date of first documented of pleural effusion, assessed up to 1 years |